100 2006 1 1-1 -
1 3 2 OTC 6 3 9 4 14 5 17 6 19 7 22 8 23 9 26 10 28 11 Lipitor 10% 29 12 30-2 -
TOP 1 5 13 9 22 22 2006 13 22-3 -
5 70% 2001 2001 4 22-4 -
60 2005 200 6-5 -
3-5 TOP 2 OTC OTC 2005 OTC NHC 2005 OTC NCH NICHOLAS HALL OTC Chris Snook OTC NHC Nicholas Hall - 6 -
OTC OTC 2004 2.8% 3.7% OTC OTC 11 8.1% OTC OTC OTC OTC OTC OTC Chris Snook 22 AYA OTC 1997 2000 OTC OTC 5 5 OTC 5 OTC OTC OTC - 7 -
NCH Nicholas Hall OTC OTC OTC OTC OTC OTC 10 OTC OTC 10 OTC 1 OTC 10 OTC Chris Snook Chris Snook OTC 13 13 OTC 70% 80% OTC - 8 -
AYA OTC We world wide Partners Viveca Chen OTC OTC 15 15 OTC TOP 3 80% 90% - 9 -
MDSCapital 900 300 1/3 30 20 2004 4000 200 400 2000-10 -
70% 20 90 3 57.8 180-2007 11 35% - 11 -
Merck 2002 3.2% / CRO CRO 70% - 12 -
Wood Mackenzie 1988-2003 GSK 2 2001 GSK Roche Novartis Aventis 20 50% Schering-Plough Abbott Merck Amgen Merck Kyorin 1999 KRP-297 Amgen Immunomedics epratuzumab Celltech NPS calcimimetics Immunex Enbrel etanercept 20 Pfizer 2003 151 53% Celebrex - 13 -
cele-coxib Lipitor atorvastatin GSK 18% TOP 4 13 7000-14 -
20 2020 l 20 ( ) - 15 -
100 500 30-16 -
TOP 5 2007 820 500 2925.5 1992 2004 52 (GSK) 1999 (Advair Seretide) (Norvasc) (Zyprexa) 2005 400 2008 700 30-17 -
( ) (ANDAs) (Lupin) Wockhardt (NDD) ( DDS) 100 2003 23.8 11 7.3 2004 3 50 2005 (FDA) 143 DMF (Drug Master Files) FDA DMF (411 ) 35 FDA - 18 -
Allergen (Sandoz) 8 10 Wockhardt 10 250 10 TOP 6 MP3-19 -
50 90% D499023 D311867 D308428 D450153 D432714 D431093 D430703 D437407 D434136 D434135 D433750 D433501 D433500 D433499 D433122 D433121 D432641 D415272 D414552 D414551 D414259 D441089 D435300 D305003 D305002 D305001 D399313 D351466 D351465 5-20 -
55% 70% - 21 -
TOP 7 18 12 1 WHO 21 antiretrovirals WHO WHO 2005 2005 500 4000 2005 400 100 300 5 1 10 1 72 6.5 3 5 2005 300 JimKim 350 PeterPiot - 22 -
2006 1 1 TOP 8 12 6 0.25g 16 17.30 20.70 0.25g 32 34.60 40.40 10.50 12.10 0.13g 18 18.20 20.85 16.55-23 -
2003 6 2004 2004 2005 2.97 65.65 2004 1.17 6 571.24 27.39 2004 1.57 2005 17.83 34.36 1.76 40.04 1999-24 -
2005 5.95 6.44 7880.43 13.26-25 -
TOP 9 2001 1996 27% 61% 10 Pfizer (atorvastatin calcium)( ) Mer ck (simvastatin)( ) BMS (pravastatin)( ) 40 FDA - 26 -
5 61% 80% 2000 600 100-27 -
TOP 10-28 -
TOP 11 Lipitor 10% (PFE) 10% 10% Lipitor -- -- A.G. Edwards - (Albert Rauch) - (Joseph Farnan) Atorvastatin -- Lipitor -- 2011 Ranbaxy Laboratories Ltd.(RBXLF) Lipitor Ranbaxy Schwegman Lundberg Woessner Kluth - (Warren Woessner) Lipitor (MRK) 7% (BMY) 3% (SGP) 5% Sanford C. Bernstein - (Richard Evans) - 29 -
10% 25.29 25.66 - (James Kelly) - (Hank McKinnell) Atorvastatin Lipitor 1997 1800 Lipitor IMS 2004 120 Sanofi-Aventis(SNY) (AZN) - (GSK) - (David Risinger) Forest Laboratories(FRX) TOP 12-30 -
1 1 49 3 49 49 49 WTO 5 9-31 -